Spruce Biosciences Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	54.08	48.91	38.75	96.34	24.49	42.75
Short-Term Investments	-	-	-	-	54.59	46.22
Cash & Short-Term Investments	54.08	48.91	38.75	96.34	79.08	88.97
Cash Growth	111.13%	26.20%	-59.77%	21.83%	-11.12%	-43.39%
Other Current Assets	0.95	3.21	5.45	5.84	4.53	2.93
Total Current Assets	55.03	52.11	44.21	102.18	83.61	91.9
Net Property, Plant & Equipment	0.6	0.67	0.93	1.18	1.4	1.48
Long-Term Investments	-	-	-	-	-	32.46
Other Long-Term Assets	0.54	0.24	0.07	0.58	0.64	0.65
Total Assets	56.17	53.02	45.21	103.95	85.65	126.49
Accounts Payable	2.68	0.94	1.3	3.33	1.43	2.82
Accrued Expenses	8.1	9.14	12.33	14.6	9.4	6.05
Current Portion of Long-Term Debt	1	-	1.62	1.62	1.62	-
Unearned Revenue	-	-	-	4.91	-	-
Total Current Liabilities	11.78	10.09	15.25	24.47	12.45	8.87
Long-Term Debt	5.46	-	0.12	1.72	3.29	4.88
Long-Term Leases	0.33	0.42	0.74	1.02	1.26	1.29
Other Long-Term Liabilities	3.94	-	0.28	0.24	0.16	0.07
Total Long-Term Liabilities	9.73	0.42	1.14	2.97	4.72	6.24
Total Liabilities	21.52	10.51	16.39	27.44	17.16	15.12
Common Stock	-	-	-	0	0	0
Additional Paid-in Capital	336.15	331.75	279.09	273.74	218.35	214.69
Accumulated Other Comprehensive Income	-	-	-	-	-0.56	-0.18
Retained Earnings	-	-	-250.27	-197.23	-149.31	-103.13
Shareholders' Equity	336.15	331.75	28.82	76.51	68.49	111.37
Total Liabilities & Equity	56.17	53.02	45.21	103.95	85.65	126.49
Total Debt	6.8	0.42	2.48	4.36	6.18	6.17
Net Cash (Debt)	47.28	48.49	36.27	91.98	72.9	82.8
Net Cash Growth	-2.48%	33.68%	-60.57%	26.17%	-11.95%	-45.17%
Net Cash Per Share	49.46	63.25	65.93	179.14	232.40	265.82
Book Value	336.15	331.75	28.82	76.51	68.49	111.37
Book Value Per Share	351.61	432.76	52.39	149.00	218.32	357.55
Tangible Book Value	336.15	331.75	28.82	76.51	68.49	111.37
Tangible Book Value Per Share	351.61	432.76	52.39	149.00	218.32	357.55